GlassScriptPhysician profile
Brian C Cey
NPI 1659939031
$2,649.90
in general payments reported to CMS, 2019-2025
37 companies · $1,246 in 2025
The $1,246 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.95 · 2022: $93.43 · 2023: $224 · 2024: $1,053 · 2025: $1,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,522.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $411.04 | 2022-2025 | |
| Novo Nordisk INC | $359.00 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $231.15 | 2022-2025 | |
| Glaxosmithkline, LLC. | $171.67 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $159.68 | 2021-2025 | Evenity, Repatha, Prolia |
| Exact Sciences Corporation | $132.79 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $109.61 | 2024-2025 | |
| Lilly USA, LLC | $108.30 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Novartis Pharmaceuticals Corporation | $100.81 | 2024-2025 | |
| Medtronic, INC. | $80.62 | 2024-2025 | Inceptiv, Minimed 780g |
| Xeris Pharmaceuticals, INC. | $80.35 | 2023-2025 | Recorlev, Gvoke Hypopen |
| Dexcom, INC. | $76.49 | 2024-2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $75.91 | 2024-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $58.05 | 2024-2025 | Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.60 | 2024 | Jardiance |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.